MTOR and cancer: The receptor tyrosine kinase EGFR regulates the activity of pro-oncogenic pathways including the mitogen activated protein kinases (MAPKs) ERK1/2 and mammalian target of rapamycin (mTOR), which both promote cancer cell proliferation.